About: Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $24.45 (+1.33%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
GLTO NASDAQ Galecto Inc
Galecto Inc share price
Atividade de preço de GLTO
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
GLTO price performance
quote.marketSignals